MYCOF

MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW (MYCOF)

About MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW (MYCOF)

Mydecine Innovations Group, Inc. is a biotechnology company, which engages in the research, drug development, and clinical trials of psilocybin products. The company was founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013 and is headquartered in Vancouver, Canada.

Details

Daily high
$0.10
Daily low
$0.10
Price at open
$0.10
52 Week High
$0.45
52 Week Low
$0.00
Market cap
118,100
Dividend yield
0.00%
Volume
34
Avg. volume
852
P/E ratio
.93

MYDECINE INNOVATNS GP INC by MYDECINE INNOVATIONS GROUP INC NEW News

Details

Daily high
$0.10
Daily low
$0.10
Price at open
$0.10
52 Week High
$0.45
52 Week Low
$0.00
Market cap
118,100
Dividend yield
0.00%
Volume
34
Avg. volume
852
P/E ratio
.93